Literature DB >> 34923284

The two faces of autophagy in oral squamous cell carcinoma.

Aisling Anderson1, Jeff O'Sullivan2.   

Abstract

OBJECTIVE: To undertake a comprehensive review of the current knowledge and understanding of autophagy in oral squamous cell carcinoma (OSCC), focusing on putative roles in tumour suppression and survival along with the influence of this cell death pathway on the development of resistance to chemotherapeutic treatment.
DESIGN: Several well utilised databases (PubMed, Medline, Google Scholar) were searched for the relevant literature using terms and keywords including but not limited too; autophagy and cancer, autophagy and OSCC, tumour survival, autophagy and oral microbiome, autophagy immunogenicity, OSCC chemoresistance.
RESULTS: Up-regulation of autophagy has been shown to promote tumour cell survival in the tumour microenvironment while in healthy cells, autophagy induction acts to prevent severe DNA mutations that can lead to cancer. Cancers utilise the autophagy pathway to promote survival during the stress of chemotherapeutic treatment and can induce resistance to chemotherapeutic drugs
CONCLUSION: The ambiguous role of autophagy within cancers is still problematic in clinical fields. Within OSCC understanding whether autophagy plays a preventive or causative role is essential and may be beneficial in determining how modulation of this pathway may impact on OSSC and oral cancer patients.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; Head and neck cancer; Oral cancer; Oral malignancies; Oral microbiome; Oral squamous cell carcinoma

Mesh:

Year:  2021        PMID: 34923284     DOI: 10.1016/j.archoralbio.2021.105321

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  1 in total

1.  Inflammation and Invasion in Oral Squamous Cell Carcinoma Cells Exposed to Electronic Cigarette Vapor Extract.

Authors:  Hannah P Robin; Courtney N Trudeau; Adam J Robbins; Emily J Chung; Erum Rahman; Olivia L Gangmark Strickland; Scott Jordan; Frank W Licari; Duane R Winden; Paul R Reynolds; Juan A Arroyo
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.